Video Shorts

2:12
Navigating JAK Inhibitors and Transplant in Myelofibrosis
5 months ago
by
Andrew Kuykendall, MD

4:33
OncLive News Roundup for the Week of 4/26
5 months ago
by
Chris Ryan(+1 more)

1:40
Highlighting Reconstructive Surgery Options in Breast Cancer
5 months ago
by
Sara Nunnery, MD, MSCI

2:12
Breast Cancer Experts Discuss Emerging Data and Desicions
5 months ago
by
Sara Nunnery, MD, MSCI(+1 more)

0:54
Examining the Potential Clinical Impact of the STRIKE Trial in RCC
5 months ago
by
Bradley A. McGregor, MD

1:04
GLP-1 Agonists Could Help Address Rising Rates of Early-Onset CRC
5 months ago
by
Colton Jones, MD

0:58
A New Era for RAS Inhibition in PDAC: From an “Undruggable” Target to a Potential Paradigm-Shifter
5 months ago
by
Brian M. Wolpin, MD, MPH

1:46
Breaking Down the Use of FES-PET/CT in Breast Cancer
5 months ago
by
Megan Kruse, MD

2:10
The Push for Individualized Risk-Stratification Strategies in Myeloma
5 months ago
by
C. Ola Landgren, MD, PhD

1:05
Is Surgery Still the Cornerstone of Curative Treatment in Esophageal Cancer?
5 months ago
by
Peter C. Enzinger, MD, Dana-Farber Cancer Institute

1:05
Spotlighting Evolutions in HER2+ Breast Cancer Management
5 months ago
by
Sara M. Tolaney, MD, MPH

1:54
Examining the Treatment Landscape of Muscle-Invasive Bladder Cancer
5 months ago
by
Matthew D. Galsky, MD

4:03
OncLive News Roundup for the Week of 4/19
5 months ago
by
Chris Ryan

1:00
Discussing the Rationale for Evaluating a ROR2-Targeting ADC in OPSCC
5 months ago
by
Alan L. Ho, MD, PhD

1:18
Highlighting the Importance of Testicular Cancer Awareness
5 months ago
by
Mina M. Fam, MD

1:04
Could GLP-1 Receptor Agonists Help Reduce CRC Risk Beyond Weight Loss?
5 months ago
by
Colton Jones, MD

2:07
Navigating Long-Term Care Following CAR T-Cell Therapy in Myeloma
5 months ago
by
Jesús Berdeja, MD

1:47
How Community Helps Oncology Professionals Achieve Work-Life Harmony
5 months ago
by
Timothy I. Shaw, PhD

0:53
Darlifarnib in Clear Cell Renal Cell Carcinoma
5 months ago
by
Adanma Ayanambakkam, MD, MS

1:20
Why Palliative Care Needs to Start Earlier for AYA Patients With Sarcoma
5 months ago
by
Vinayak Venkataraman, MD

2:09
Treatment Considerations Following Covalent BTK Inhibitors in CLL
5 months ago
by
Alexey V. Danilov, MD, PhD

1:22
Highlighting the NCCN Advocacy Academy Program
5 months ago
by
Alyssa Schatz, DrPH, MSW

2:35
Selecting Second-Line Therapy in R/R Myeloma
5 months ago
by
Noopur S. Raje, MD

0:55
Staging Pitfalls in Esophageal Cancer Could Alter Curative Intent Decisions
5 months ago
by
Peter C. Enzinger, MD, Dana-Farber Cancer Institute

0:42
The Potential Role of Tumor-Informed ctDNA Testing in Early TNBC
5 months ago
by
Marija Balic, MD, PhD

1:20
Should We Prescribe Exercise Like We Prescribe Chemotherapy in Sarcoma?
5 months ago
by
Vinayak Venkataraman, MD

4:12
OncLive News Roundup for the Week of 4/12
5 months ago
by
Chris Ryan(+1 more)

0:45
How Should Bone Pain Be Interpreted in Patients With Cancer on Bone-Modifying Agents?
5 months ago
by
R. Lor Randall, MD, FACS

1:02
Raising Awareness for PD-L1 Testing for Head and Neck Cancer
5 months ago
by
Fangdi Sun, MD

0:36
Safely Incorporating Integrative Medicine Into Breast Oncology
5 months ago
by
Lillian Rodich, MSPAS, MPH
Advertisement
Advertisement
Trending on OncLive
1
ASCO Issues First Living Guideline for Systemic Treatment of Recurrent Ovarian Cancer
2
OSE2101 Plus Pembrolizumab as Maintenance Boosts PFS in Platinum-Sensitive Ovarian Cancer
3
FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer
4
The OncFive: Top Oncology Articles for the Week of 9/14/2026
5
